Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R L Camp

Showing results (21-30 of 24) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 24 results.
Regulatory Peptides|February 11, 2010
The CCK(2) receptor antagonist, YF476, inhibits Mastomys ECL cell hyperplasia and gastric carcinoid tumor developmentM Kidd, Z-L Siddique, I Drozdov, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 9, 2005
beta-Catenin functions mainly as an adhesion molecule in patients with squamous cell cancer of the head and neckZiwei Yu, Paul M Weinberger, Elayne Provost, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|September 15, 2006
Automated quantitative analysis of DCC tumor suppressor protein in ovarian cancer tissue microarray shows association with beta-catenin levels and outcome in patients with epithelial ovarian cancerA Bamias, Z Yu, P M Weinberger, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 2, 2012
c-Met is a prognostic marker and potential therapeutic target in clear cell renal cell carcinomaG T Gibney, S A Aziz, R L Camp, et al.
Pageof 3

Showing results (21-30 of 24) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 24 results.
Regulatory Peptides|February 11, 2010
The CCK(2) receptor antagonist, YF476, inhibits Mastomys ECL cell hyperplasia and gastric carcinoid tumor developmentM Kidd, Z-L Siddique, I Drozdov, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 9, 2005
beta-Catenin functions mainly as an adhesion molecule in patients with squamous cell cancer of the head and neckZiwei Yu, Paul M Weinberger, Elayne Provost, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|September 15, 2006
Automated quantitative analysis of DCC tumor suppressor protein in ovarian cancer tissue microarray shows association with beta-catenin levels and outcome in patients with epithelial ovarian cancerA Bamias, Z Yu, P M Weinberger, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 2, 2012
c-Met is a prognostic marker and potential therapeutic target in clear cell renal cell carcinomaG T Gibney, S A Aziz, R L Camp, et al.
Pageof 3